Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-19T10:33:02.625Z Has data issue: false hasContentIssue false
  • English
  • Français

Responses of volunteers to inactivated influenza virus vaccines

Published online by Cambridge University Press:  25 March 2010

R. Jennings ,
C. W. Potter ,
P. M. O. Massey ,
B. I. Duerden ,
J. Martin  and
A. M. Bevan
R. Jennings
Affiliation:
Department of Virology, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX
C. W. Potter
Affiliation:
Department of Virology, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX
P. M. O. Massey
Affiliation:
Regional Medical Advisor, Central Electricity Generating Board, Haslucks Green Road, Shirley, Solihull, Warwickshire
B. I. Duerden
Affiliation:
Department of Medical Microbiology and Department of Medicine, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX
J. Martin
Affiliation:
Department of Medical Microbiology and Department of Medicine, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX
A. M. Bevan
Affiliation:
Glaxo Operations (U.K.) Ltd, Speke Biologicals, Speke, Liverpool L24 9JD
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Three different types of bivalent influenza virus vaccine, a whole virus, an aqueous-surface-antigen vaccine and an adsorbed-surface-antigen vaccine were tested at three dosage levels in volunteers primed with respect to only one of the haemagglutinin antigens present in the vaccines.

The local and systemic reactions to all three vaccine types were mild in nature and, following first immunization, the aqueous-surface-antigen vaccine was the least reactogenic. The serum haemagglutination-inhibiting antibody response to the A/Victoria/75 component of the vaccines, to which the volunteer population was primed, was greatest following immunization with the aqueous-surface-antigen vaccine; the greatest antibody response to the A/New Jersey/76 component of the vaccines was observed following immunization with whole virus vaccine.

Type
Research Article
Information
Journal of Hygiene , Volume 86 , Issue 1 , February 1981 , pp. 1 - 16
Copyright
Copyright © Cambridge University Press 1981

References

REFERENCES

Aymard-Henry, M., Coleman, M. T., Dowdle, W. R., Laver, W. G., Schild, G. C. & Webster, R. G. (1973). Influenza virus neuraminidase and neuraminidase-inhibition test procedures. Bulletin of the World Health Organization 48, 199–202.Google Scholar
Barry, D. W., Mayner, R. E., Hochstein, H. D., Dunlap, R. C., Rastogi, S. C., Hannah, J. E., Blackburn, R. J., Sullivan, J. L. & Gerety, R. J. (1976). Comparative trial of influenza vaccines. II. Adverse reactions in children and adults. American Journal of Epidemiology 104, 47–59.Google Scholar
Barry, D. W., Staton, E. & Mayner, R. E. (1974). Inactivated influenza vaccine efficacy: diminished antigenicity of split-product vaccines in mice. Infection and Immunity 10, 1329–36.Google Scholar
Bevan, A. M., Furminger, I. G. S. & Smith, C. H. (1975). Neuraminidase assay of influenza vaccines. Developments in Biological Standardization 18, 173–80.Google Scholar
Brady, M. I. & Furminger, I. G. S. (1976). A surface antigen influenza vaccine. I. Purification of haemagglutinin and neuraminidase proteins. Journal of Hygiene 77, 161–72.Google Scholar
Brady, M. I., Furminger, I. G. S. & Stones, P. B. (1976). An adsorbed surface-antigen influenza vaccine and its serological activity in volunteers. Postgraduate Medical Journal 52, 368–72.Google Scholar
Brandon, F. B., Barret, C. D. Jr., Hook, A. E. & Lease, G. O. (1967). Human febrile response to influenza virus or its ether isolated haemagglutinins. Proceedings of the Society for Experimental Biology and Medicine 125, 683–6.Google Scholar
Eastwood, L. M., Jennings, R., Milner, R. D. G. & Potter, C. W. (1979). Reactogenicity and immunogenicity of a surface-antigen-adsorbed influenza virus vaccine in children. Journal of Clinical Pathology 32, 534–7.Google Scholar
Gross, P. A. (1977). Reactogenicity and immunogenicity of bivalent influenza vaccine in one- and two-dose trials in children: a summary. Journal of Infectious Diseases 136S, S616–25.CrossRefGoogle Scholar
Gross, P. A. & Ennis, F. A. (1977). Influenza vaccine: split-product versus whole-virus types – how do they differ? New England Journal of Medicine 296, 567–8.CrossRefGoogle Scholar
Howells, C. H. L., Evans, A. D. & Vesselinova-Jenkins, C. (1973). Effects of two doses of influenza vaccine in stimulating antibody in volunteers. Lancet i, 1436–8.CrossRefGoogle Scholar
Hobson, D., Curry, R. L., Beare, A. S. & Ward-Gardner, A. (1972). The role of haemagglutinin-inhibiting antibody in protection against challenge infection with A2 and B influenza viruses. Journal of Hygiene 70, 767–77.Google Scholar
Jennings, R., Clark, A., Oxford, J. S., Hockley, D. J. & Potter, C. W. (1978). Reactogenicity and immunogenicity of whole and ether-tween split influenza A virus vaccines in volunteers. Journal of Infectious Diseases 138, 577–86.Google Scholar
Jennings, R., Potter, C. W., McLaren, C. & Brady, M. (1975). A new, surface-antigen-adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters. Journal of Hygiene 75, 341–52.Google Scholar
McLaren, C., Verbonitz, M. W., Daniel, S., Grubbs, S. E. & Ennis, F. A. (1977). Effect of priming infection on serologic response to whole and subunit influenza virus vaccines in animals. Journal of Infectious Diseases 136S, S706–11.Google Scholar
Marine, W. M. & Stuart-Harris, C. H. (1976). Reactions and serologic responses in young children and infants after administration of inactivated monovalent influenza A vaccine. Journal of Pediatrics 88, 26–30.Google Scholar
Monto, A. S. & Kendal, A. P. (1973). Effects of neuraminidase antibody on Hong Kong influenza. Lancet i, 623–5.CrossRefGoogle Scholar
Nicholson, K. G., Tyrrell, D. A. J., Harrison, P., Potter, C. W., Jennings, R., Clark, A., Schild, G. C., Wood, J. M., Yetts, R., Seagroatt, V., Huggins, A. & Anderson, S. G. (1979). Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. Journal of Biological Standardization 7, 123–36.Google Scholar
Pandemic Working Group of the Medical Research Council (1977). Antibody responses and reactogenicity of graded doses of inactivated influenza A/New Jersey/76 whole virus vaccine in humans. Journal of Infectious Diseases 136S, S475–83.Google Scholar
Parkman, P. D., Galasso, G. J., Top, F. H. Jr. & Noble, G. R. (1976). Summary of clinical trials of influenza vaccines. Journal of Infectious Diseases 134, 100–7.Google Scholar
Potter, C. W., Clark, A., Jennings, R., Schild, G. C., Wood, J. M. & McWilliams, P. K. A. (1980). Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccines in unprimed children. Journal of Biological Standardization 8, 35–48.Google Scholar
Potter, C. W., Jennings, R., McLaren, C., Edey, D. & Stuart-Harris, C. H. (1975). A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group. Journal of Hygiene 75, 353–62.Google Scholar
Potter, C. W., Jennings, R., Phair, J. P., Clark, A. & Stuart-Harris, C. H. (1977). Dose-response relationship after immunisation of volunteers with a new surface-antigen-adsorbed influenza virus vaccina. Journal of Infectious Diseases 135, 423–31.Google Scholar
Ruben, F. L. & Jackson, G. C. (1972). A new subunit influenza vaccine: acceptability compared with standard vaccines and effect of dose on antigenicity. Journal of Infectious Diseases 135, 656–64.Google Scholar
Welty, P. B. Jr., Epstein, B., O'Brien, J., Brackett, R. G., Brandon, F. B. & Shillis, J. L. (1977). Reactions and serologic responses after administration of inactivated monovalent influenza A/Swine virus vaccines. I. Immunization of children and adults with influenza A/Shope virus vaccines. Journal of Infectious Diseases 136S, S604–8.Google Scholar
Wood, J. M., Schild, J. C., Newman, R. W. & Seagroatt, V. (1977). An improved single radial immunodiffusion technique for the assay of influenza haemagglutinin antigen. Application for potency determination of inactivated whole virus and subunit vaccines. Journal of Biological Standardization 5, 237–47.Google Scholar
Wright, P. F., Dolin, R. & La Montaigne, J. R. (1976). Summary of clinical trials of influenza vaccines. II. Journal of Infectious Diseases 134, 633–8.Google Scholar
Wright, P. F., Bryant, J. D. & Karzon, D. T. (1980). Comparison of influenza B virus infections among infants, children and young adults. Journal of Infectious Diseases 141, 430–5.Google Scholar